Crab blood to remain big pharma's standard as industry group rejects substitute

Animal rights groups have been pushing a synthetic alternative to horseshoe crab blood in drug safety testingHorseshoe crabs’ icy-blue blood will remain the drug industry’s standard for safety tests after a powerful US group ditched a plan to give equal status to a synthetic substitute pushed by Swiss biotech Lonza and animal welfare groups.The crabs’ copper-rich blood clots in the presence of bacterial endotoxins and has long been used in tests to detect contamination in shots and infusions. Continue reading… Source – Full Article https://www.theguardian.com/environment/2020/may/31/crab-blood-to-remain-big-pharmas-standard-as-industry-group-rejects-substitute